In influenza, MASLD patients also displayed exaggerated interferon-induced chemokine CXCL10 and immunoregulatory TGF-β1 and IL-10 responses, possibly enhancing tissue damage and impairing viral clearance. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.